These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4490729)

  • 1. The possible role of antiarrhythmic drugs in the prevention of sudden death.
    McAllister RG
    Heart Lung; 1973; 2(6):857-61. PubMed ID: 4490729
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents.
    Murnaghan MF
    Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Johnson GL; Ehrreich SJ; el-Hage AN; Balazs T
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):351-64. PubMed ID: 3704313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacing.
    Rothfeld EL; Zucker IR; Tiu R; Parsonnet V
    Am J Cardiol; 1970 Jul; 26(1):52-5. PubMed ID: 5427832
    [No Abstract]   [Full Text] [Related]  

  • 5. The actions and clinical use of the newer antiarrhythmic drugs.
    Hayes AH
    Ration Drug Ther; 1972 Jul; 6(7):1-6. PubMed ID: 5085124
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction.
    Chung EK
    Postgrad Med; 1973 Oct; 54(4):197-203. PubMed ID: 4729173
    [No Abstract]   [Full Text] [Related]  

  • 7. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrilation threshold curves and anti-arrhythmic drugs.
    Vanremoortere E; Wauters E
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):476-9. PubMed ID: 5715418
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic drugs.
    Moses HW; Yu PN
    J Clin Pharmacol; 1980 Oct; 20(10):598-618. PubMed ID: 7002961
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of sudden coronary death by chronic antiarrhythmic therapy.
    Koch-Weser J
    Adv Cardiol; 1978; 25():206-28. PubMed ID: 360790
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of ventricular arrhythmias after myocardial infarction.
    Kidner PH
    J R Coll Physicians Lond; 1977 Jul; 11(4):352-62. PubMed ID: 886493
    [No Abstract]   [Full Text] [Related]  

  • 14. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985.
    Hallstrom AP; Cobb LA; Yu BH; Weaver WD; Fahrenbruch CE
    Am J Cardiol; 1991 Oct; 68(10):1025-31. PubMed ID: 1927915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antidysrhythmic drugs.
    Yeh BK; Gosselin AJ
    Ration Drug Ther; 1975 Jan; 9(1):1-7. PubMed ID: 1129496
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of extrasystole (ventricular and atrial extrasystoles)].
    Kanazawa T; Miura M; Ono Y; Hashimoto S
    Nihon Rinsho; 1974 Sep; 32(9):2865-70. PubMed ID: 4140929
    [No Abstract]   [Full Text] [Related]  

  • 17. Current therapy of ectopic cardiac arrhythmias.
    Helfant RH
    Med Times; 1970 Jan; 98(1):118-23. PubMed ID: 5411845
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethyl-3-ethoxycarbonyl-4-hydroxy-2H-1,2-benzothiazine-2-acetate-1,1-dioxide, a compound producing ventricular arrhythmias.
    Pruss TP
    Toxicol Appl Pharmacol; 1969 Jan; 14(1):1-5. PubMed ID: 4180304
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction.
    Jewitt DE; Mercer CJ; Hubner PJ; Shillingford JP
    Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358169
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug control of cardiac arrhythmias during anaesthesia.
    Payne JP
    Ann R Coll Surg Engl; 1970 Mar; 46(3):143-4. PubMed ID: 5445659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.